Article
The contribution of multiplexing single cell RNA sequencing in acute myeloid leukemia
2023-02-22
Abstract excerpt
After decades during which the treatment of acute myeloid leukemia consisted in cytarabine + anthracycline, targeted therapies have appeared, first based on monoclonal antibodies (anti-CD52, anti-CD123) and then on specific inhibitors of molecular mutations (anti-IDH, IDH2 or FLT3). What should be the place of these therapeutic options considering the tumor heterogeneity inherent to leukemia diagnosis and the clon...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f7eb5360-7732-586a-a8aa-3fea730b1eea
- DOI
- 10.21203/rs.3.rs-2565353/v1
